New infographics on EDCs

Health and Environment Alliance releases infographics on endocrine disrupting chemicals, focuses on the need to accommodate low dose effects and science advances into risk assessment

FPF Workshop 2018: Improving chemical safety by new science

Presentations at Food Packaging Forum 2018 workshop cover predictive toxicology, computational methodologies, green chemistry

CLARITY-BPA webinars: Key messages

Carnegie Mellon University and FDA hold webinars on CLARITY-BPA academic research and guideline studies; FDA upholds importance of high-dose effects; academic researchers highlight significant low-dose effects

Opinion: FDA ‘rushing to judgement’ on BPA

Article in Environmental Health News discusses main goal of CLARITY-BPA program and U.S. FDA’s premature conclusions on BPA hazards

Webinar on CLARITY-BPA core study

U.S. Food and Drug Administration hosts webinar on guideline studies conducted within CLARITY-BPA program, September 13, 2018; registration now open

Webinar on CLARITY-BPA academic studies

Carnegie Mellon University holds webinar on independent academic studies on bisphenol A within CLARITY-BPA program, September 12, 2018; registration now open

Focus on ‘BPA-free’ products

Article discusses common BPA substitutes and whether products labeled ‘BPA-free’ are safer

More evidence on hazard potential of BPA and BPS

Endocrine Society highlights 3 scientific studies investigating effects of bisphenol A and its common substitute bisphenol S on body weight, liver development, and breast cancer

Evidence on BPA’s ubiquity and low-dose effects

New study reviews and substantiates ubiquitous occurrence of bisphenol A in the environment and adverse health effects from low-dose exposures to it

Assessing low-dose toxicity of EDCs

New report by the National Academies of Sciences presents strategy to evaluate low-dose effects of endocrine active substances, provides systematic reviews for phthalates and PBDEs